Dow Up0.07% Nasdaq Up0.61%

More On RBM.TO

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials


Response Biomedical Corp. (RBM.TO)

-Toronto
0.98 0.00(0.00%) 3:34PM EST
ProfileGet Profile for:
Response Biomedical Corp.
1781 - 75th Avenue West
Vancouver, BC V6P 6P2
Canada - Map
Phone: 604-456-6010
Fax: 604-456-6066
Website: http://www.responsebio.com

Details 
Index Membership:N/A
Sector:Healthcare
Industry:Medical Appliances & Equipment
Full Time Employees:65

Business Summary 

Response Biomedical Corp. is engaged in the research, development, commercialization, and distribution of diagnostic technologies for the medical central-lab testing, point of care (POC) testing, and on-site environmental testing markets. The POC and on-site diagnostic tests are non-laboratory based tests performed using portable hand-held devices, compact desktop analyzers, single-use test cartridges, and/or dipsticks. It provides RAMP system, which is a portable fluorescence immunoassay-based diagnostic technology that combines the performance of a clinical lab with the convenience of a dipstick test. The company’s RAMP tests are used in the early detection of heart attack, congestive heart failure, influenza A+B, the respiratory syncytial virus, and environmental detection of West Nile Virus; and biodefense applications, including the rapid on-site detection of anthrax, smallpox, ricin, and botulinum toxin. Response Biomedical Corp. sells its products through distributors primarily in China, the United States, Asia, Europe, Canada, and internationally. The company was founded in 1980 and is headquartered in Vancouver, Canada.

Key Statistics


Company Websites 
Home Page
Search Yahoo! for:
More on Response Biomedical Corp.

Key Executives 
 PayExercised
Dr. Anthony F. Holler M.D., 63
Interim Chief Exec. Officer, Treasurer, Director, Chairman of Compensation Committee, Member of Audit Committee and Member of Corp. Governance & Nominating Committee
32.00K0.00
Mr. William J. Adams C.A., 52
Chief Financial Officer and Corp. Sec.
243.00K0.00
Dr. Barbara R. Kinnaird Steen Ph.D., 47
Chief Operating Officer and VP of R&D
N/AN/A
Mr. Bill Wickson ,
Director of Investor Relations
N/AN/A
Mr. Anastasios Tsonis , 34
Corp. Controller
N/AN/A
Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in CAD.